000 01235 a2200325 4500
005 20250518050500.0
264 0 _c20200114
008 202001s 0 0 eng d
022 _a1465-993X
024 7 _a10.1186/s12931-019-1108-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSingh, Dave
245 0 0 _aWeighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.
_h[electronic resource]
260 _bRespiratory research
_cJul 2019
300 _a141 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Cortex Hormones
_xpharmacology
650 0 4 _aAdrenergic beta-2 Receptor Agonists
_xpharmacology
650 0 4 _aExercise Tolerance
_xdrug effects
650 0 4 _aForced Expiratory Volume
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMuscarinic Antagonists
_xpharmacology
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdiagnosis
650 0 4 _aTreatment Outcome
700 1 _aD'Urzo, Anthony D
700 1 _aDonohue, James F
700 1 _aKerwin, Edward M
773 0 _tRespiratory research
_gvol. 20
_gno. 1
_gp. 141
856 4 0 _uhttps://doi.org/10.1186/s12931-019-1108-9
_zAvailable from publisher's website
999 _c29882916
_d29882916